Cholesterol emboli syndrome natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Cholesterol emboli syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Reference...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cholesterol emboli syndrome}} | {{Cholesterol emboli syndrome}} | ||
{{CMG}} | |||
==Overview== | |||
==Natural History, Complications and Prognosis== | |||
* Many patients go on to amputation, renal failure, other organ system failure, and/or death. | |||
* Mortality has not been well studied. The diagnosis may be difficult to make, and requires suspicion based upon clinical findings that often mimic other diseases. Therefore, the correct diagnosis is often never made, so the natural history and prognosis of all patients with CES is difficult to ascertain. | |||
* Nevertheless, mortality been reported to be as high as 37-90%, biased by selection and report bias. | |||
* Given the pathogenesis, one would expect a spectrum of disease, with probably significant numbers of subclinical, good prognosis patients. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Revision as of 14:25, 27 September 2012
|
Cholesterol emboli syndrome Microchapters |
|
Differentiating Cholesterol emboli syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cholesterol emboli syndrome natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Cholesterol emboli syndrome natural history, complications and prognosis |
|
FDA on Cholesterol emboli syndrome natural history, complications and prognosis |
|
CDC on Cholesterol emboli syndrome natural history, complications and prognosis |
|
Cholesterol emboli syndrome natural history, complications and prognosis in the news |
|
Blogs on Cholesterol emboli syndrome natural history, complications and prognosis |
|
Directions to Hospitals Treating Cholesterol emboli syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History, Complications and Prognosis
- Many patients go on to amputation, renal failure, other organ system failure, and/or death.
- Mortality has not been well studied. The diagnosis may be difficult to make, and requires suspicion based upon clinical findings that often mimic other diseases. Therefore, the correct diagnosis is often never made, so the natural history and prognosis of all patients with CES is difficult to ascertain.
- Nevertheless, mortality been reported to be as high as 37-90%, biased by selection and report bias.
- Given the pathogenesis, one would expect a spectrum of disease, with probably significant numbers of subclinical, good prognosis patients.